Prevención de recaídas en la esquizofreniaPropuesta de un programa de intervención durante la fase prodrómica

  1. Juan Francisco Godoy García
  2. María Caballero Martínez
  3. Débora Godoy-Izquierdo
  4. Mª Luisa Vázquez Pérez
  5. José A. Muela Martínez
Revista:
ReiDoCrea: Revista electrónica de investigación y docencia creativa

ISSN: 2254-5883

Any de publicació: 2016

Volum: 5

Pàgines: 56-68

Tipus: Article

DOI: 10.30827/DIGIBUG.40752 DIALNET GOOGLE SCHOLAR lock_openDIGIBUG editor

Altres publicacions en: ReiDoCrea: Revista electrónica de investigación y docencia creativa

Objectius de Desenvolupament Sostenible

Resum

Schizophrenia is a chronic, severe mental disorder affecting 1% of the adult population worldwide (WHO, 2014). The course of the prodromal stage generally begins with experiencing negative clinical symptoms, followed by positive symptoms, which usually increase in frequency, duration and intensity as the episode of psychosis approaches. A 24-session multi-component intervention -psychoeducation and adherence to treatment, early detection and intervention on initial signs and self-efficacy strengthening- is proposed herein, which is aimed at patients with schizophrenia and their relatives. The intervention aims to help them in detecting and modifying the main prodromal markers by enhancing patients' and relatives' skills for preventing or managing a relapse, in order to avoid or delay the new psychotic crisis. Consequently, it can be expected that patients' understanding of their disease and their medication adherence will improve, as well as their capability for recognizing and acting on the first signs of a possible relapse and their self-efficacy expectations. It can be also expected that relapse rates will be reduced and, ultimately, that patients' clinical status and quality of life will be enhanced. Relatives are expected to show enhanced capability for helping the patient in all the above and, as a consequence, their disease-related burden as caregivers will be reduced and their quality of life improved.

Referències bibliogràfiques

  • Álvarez-Jiménez, A., Priede, A., Hetrick, S. E., Bendall, S., Killackey, E., Parker, A. G., McGorry, P. D. y Gleeson, J. F. (2012). Risk factors for relapse following treatment for first episode psychosis: A systematic review and metaanalysis of longitudinal studies. Schizophrenia Research, 139, 116-128.
  • American Psychological Association, Society of Clinical Psychology (2013). Psychological treatments. Recuperado el 14 de Abril de 2015, de http://www.div12.org/psychological-treatments/treatments/.
  • American Psychiatric Association (2014). Guía de consulta de los criterios diagnósticos del DSM-5®: Spanish Edition of the Desk Reference to the Diagnostic Criteria From DSM-5®. Washington, DC: American Psychiatric Association.
  • Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X. y Conley, R. R. (2010). The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry, 10, 1-7.
  • Britto, J. G. (2014). Relapse prevention among caregivers of patients with schizophrenia. Asian Journal of Nursing Education and Research, 4, 140-144.
  • Eisner, E., Barrowclough, C., Lobban, F. y Drake, R. (2014). Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse. BMC Psychiatry, 14, 1-14.
  • Godoy, J. F., Godoy-Izquierdo, D. y Vázquez, M. L. (2012). Programa de entrenamiento en autoeficacia para el afrontamiento del estrés en pacientes con esquizofrenia. En Valencia, M. (Ed.), Alternativas terapéuticas para la esquizofrenia (pp. 425-490). México: Herder.
  • Godoy, J. F., Muela, J. A. y Godoy-Izquierdo, D. (2012). Prevención de recaídas en la esquizofrenia. En Valencia, M. (Ed.), Alternativas terapéuticas para la esquizofrenia (pp. 73-137). México: Herder.
  • Godoy, J. F., Muela, J. A., Sánchez-Barrera, M. B., Sánchez-Huete, J. R. L., Pérez, M. y Lorite, A. (1995). Síntomas prodrómicos preepisodio/marcadores de vulnerabilidad en la predicción y prevención de recaídas en la esquizofrenia. Psicología Conductual, 3, 159-172.
  • Klingberg, S., Wittorf, A., Fischer, A., Jakob-Deters, K., Buchkremer, G. y Wiedemann, G. (2010). Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia. Acta Psychiatrica Scandinavica,121, 340-350.
  • Larson, M. K., Walker, E. F. y Compton, M. T. (2010). Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Review of Neurotherapeutics, 10, 1347-1359.
  • McKenna, P. J. y Mortimer, A. M. (2014). Current and future treatment modalities in schizophrenia: Novel antipsychotic drugs and cognitive therapy. Expert Review of Neurotherapeutics, 14, 67-73.
  • Montaño, L., Nieto, T. y Mayorga, N. (2013). Esquizofrenia y tratamientos psicológicos: Una revisión teórica. Revista Vanguardia Psicológica Clínica Teórica y Práctica, 4, 86-107.
  • Mueser, K. T. y Cook, J. A. (2014). Rising to the challenge of first episode psychosis: The NIMH Recovery After Initial Schizophrenia Episode (RAISE) Initiative. Psychiatric Rehabilitation Journal, 37, 267–269.
  • Mueser, K. T., Deavers, F., Penn, D. L. y Cassisi, J. E. (2013). Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology, 9, 465-497.
  • Olivares, J. M., Sermon, J., Hemels, M. y Schreiner, A. (2013). Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review. Annals of General Psychiatry, 12, 1-11.
  • Organización Mundial de la Salud. (2014). Esquizofrenia. Recuperado el 7 de Marzo de 2015, de http://www.who.int/mediacentre/factsheets/fs397/es/
  • Prasko, J., Vrbova, K., Latalova, K. y Mainerova, B. (2011). Psychoeducation for psychotic patients. Biomedical Papers of the Medical Faculty of Palacký University, Olomouc, Czech Republic, 155, 385-396.
  • Robles, R., Páez, F. y González, J. (2012). Terapia cognitivo-conductual para los trastornos psicóticos: Fundamentos, evaluación y aplicación a propósito de un caso. En Valencia, M. (Ed.), Alternativas terapéuticas para la esquizofrenia (pp. 331-361). México: Herder.
  • Samalin, L., Blanc, O. y Llorca, P. M. (2010). Optimizing treatment of schizophrenia to minimize relapse. Expert Review of Neurotherapeutics, 10, 147-150.
  • Shean, G. D. (2007). Recent developments in psychosocial treatments for schizophrenic patients. Expert Review of Neurotherapeutics, 7, 817-827.
  • Valencia, M., Liberman, R. P., Rascón, M. L. y Juárez, F. (2012). Habilidades psicosociales para la esquizofrenia. En Valencia, M. (Ed.), Alternativas terapéuticas para la esquizofrenia (pp. 23-71). México: Herder.
  • Velthorst, E., Koeter, M., van der Gaag, M., Nieman, D. H., Fett, A. K., Smit, F., Staring, A. B. P., Meijer, C. y de Haan, L. (2015). Adapted cognitive–behavioural therapy required for targeting negative symptoms in schizophrenia: Meta-analysis and meta-regression. Psychological Medicine, 45, 453-465.
Fuente de los datos: Dialnet